These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 21538882

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
    Heo SH, Lee SJ, Ryoo HM, Park JY, Cho JY.
    Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
    [Abstract] [Full Text] [Related]

  • 6. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.
    Abd Hamid UM, Royle L, Saldova R, Radcliffe CM, Harvey DJ, Storr SJ, Pardo M, Antrobus R, Chapman CJ, Zitzmann N, Robertson JF, Dwek RA, Rudd PM.
    Glycobiology; 2008 Dec; 18(12):1105-18. PubMed ID: 18818422
    [Abstract] [Full Text] [Related]

  • 7. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
    Yu KH, Rustgi AK, Blair IA.
    J Proteome Res; 2005 Dec; 4(5):1742-51. PubMed ID: 16212428
    [Abstract] [Full Text] [Related]

  • 8. Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer.
    Bharti A, Ma PC, Maulik G, Singh R, Khan E, Skarin AT, Salgia R.
    Anticancer Res; 2004 Dec; 24(2C):1031-8. PubMed ID: 15154618
    [Abstract] [Full Text] [Related]

  • 9. Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum.
    Zhao J, Simeone DM, Heidt D, Anderson MA, Lubman DM.
    J Proteome Res; 2006 Jul; 5(7):1792-802. PubMed ID: 16823988
    [Abstract] [Full Text] [Related]

  • 10. N-linked glycan changes of serum haptoglobin β chain in liver disease patients.
    Zhang S, Shu H, Luo K, Kang X, Zhang Y, Lu H, Liu Y.
    Mol Biosyst; 2011 May; 7(5):1621-8. PubMed ID: 21380457
    [Abstract] [Full Text] [Related]

  • 11. Dissociation profile of protonated fucosyl glycopeptides and quantitation of fucosylation levels of glycoproteins by mass spectrometry.
    Tajiri M, Kadoya M, Wada Y.
    J Proteome Res; 2009 Feb; 8(2):688-93. PubMed ID: 19099505
    [Abstract] [Full Text] [Related]

  • 12. The Haptoglobin β chain as a supportive biomarker for human lung cancers.
    Kang SM, Sung HJ, Ahn JM, Park JY, Lee SY, Park CS, Cho JY.
    Mol Biosyst; 2011 Apr; 7(4):1167-75. PubMed ID: 21253648
    [Abstract] [Full Text] [Related]

  • 13. Glycoproteomic analysis and molecular modeling of haptoglobin multimers.
    Boonyapranai K, Tsai HY, Chen MC, Sriyam S, Sinchaikul S, Phutrakul S, Chen ST.
    Electrophoresis; 2011 Jun; 32(12):1422-32. PubMed ID: 21692080
    [Abstract] [Full Text] [Related]

  • 14. Haptoglobin and posttranslational glycan-modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer.
    Hoagland LF, Campa MJ, Gottlin EB, Herndon JE, Patz EF.
    Cancer; 2007 Nov 15; 110(10):2260-8. PubMed ID: 17918261
    [Abstract] [Full Text] [Related]

  • 15. Differentiation between isomeric triantennary N-linked glycans by negative ion tandem mass spectrometry and confirmation of glycans containing galactose attached to the bisecting (beta1-4-GlcNAc) residue in N-glycans from IgG.
    Harvey DJ, Crispin M, Scanlan C, Singer BB, Lucka L, Chang VT, Radcliffe CM, Thobhani S, Yuen CT, Rudd PM.
    Rapid Commun Mass Spectrom; 2008 Apr 15; 22(7):1047-52. PubMed ID: 18327885
    [Abstract] [Full Text] [Related]

  • 16. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
    Hamrita B, Chahed K, Trimeche M, Guillier CL, Hammann P, Chaïeb A, Korbi S, Chouchane L.
    Clin Chim Acta; 2009 Jun 27; 404(2):111-8. PubMed ID: 19306859
    [Abstract] [Full Text] [Related]

  • 17. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
    Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ.
    Am J Clin Oncol; 2008 Apr 27; 31(2):133-9. PubMed ID: 18391596
    [Abstract] [Full Text] [Related]

  • 18. Analysis of N-glycan in serum glycoproteins from db/db mice and humans with type 2 diabetes.
    Itoh N, Sakaue S, Nakagawa H, Kurogochi M, Ohira H, Deguchi K, Nishimura S, Nishimura M.
    Am J Physiol Endocrinol Metab; 2007 Oct 27; 293(4):E1069-77. PubMed ID: 17666489
    [Abstract] [Full Text] [Related]

  • 19. Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays.
    Ueda K, Fukase Y, Katagiri T, Ishikawa N, Irie S, Sato TA, Ito H, Nakayama H, Miyagi Y, Tsuchiya E, Kohno N, Shiwa M, Nakamura Y, Daigo Y.
    Proteomics; 2009 Apr 27; 9(8):2182-92. PubMed ID: 19322776
    [Abstract] [Full Text] [Related]

  • 20. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects.
    Fujimura T, Shinohara Y, Tissot B, Pang PC, Kurogochi M, Saito S, Arai Y, Sadilek M, Murayama K, Dell A, Nishimura S, Hakomori SI.
    Int J Cancer; 2008 Jan 01; 122(1):39-49. PubMed ID: 17803183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.